Skip to main content

Table 2 Colorectal cancer studies reporting on copy number alterations

From: Copy number alterations and allelic ratio in relation to recurrence of rectal cancer

 

Studies

 

Origin of tissues

Method

Total CRC

Rectum

Colon

TNM stage

     

Figure 1 A

#

Figure 1 B

#

Figure 1 C

#

1

Schlegel et al.

1995

Germany

CGH

yes

12

no

(x)

yes

12

 

2

Ried et al.

1996

Germany

CGH

yes

16

yes

6

yes

10

2/3/(4)

3

Meijer et al.

1998

the Netherlands

CGH

yes

14

yes

7

yes

7

 

4

Nakao et al.

1998

Japan

CGH

yes

9

no

0

yes

9

(1)/3

5

Paredes-Zaglul et al.

1998

USA

CGH

yes

9

yes

2

yes

7

(3)/4

6

Al-Mulla et al.

1999

UK

CGH

yes

12

no

(x)

no

(x)

2/3

7

De Angelis et al.

1999

Norway

CGH

yes

45

no

(x)

no

(x)

2/3/4

8

Georgiades et al.

1999

UK

CGH

yes

17

no

(11)

no

(6)

1/2/3

9

Korn et al.

1999

USA

CGH

yes

6

no

(0)

yes

6

2/3/4

10

Aust et al.

2000

USA/Germany

CGH

yes

42

no

(7)

no

(35)

1/2/3/4

11

Aragane et al.

2001

Japan

CGH

yes

30

no

(x)

no

(x)

1/2/3/4

12

Chan et al.

2001

China/UK

CGH

yes

16

no

(x)

no

(x)

2/3/4

13

De Angelis et al.

2001

Norway

CGH

yes

67

no

(x)

no

(x)

1/2/3/4

14

Nakao et al.

2001

Japan

CGH

yes

35

no

(13)

no

(22)

2/3/4

15

Rooney et al.

2001

USA

CGH

yes

29

no

(4)

no

(25)

3

16

Hermsen et al.

2002

the Netherlands

CGH

yes

82

no

(x)

no

(x)

1/(2)

17

Knösel et al.

2002

Germany

CGH

yes

15

no

(x)

no

(x)

 

18

Alcock et al.

2003

UK

CGH

yes

17

yes

6

yes

11

 

19

Ghadimi et al.

2003

Germany

CGH

yes

50

yes

18

yes

32

1/2/3

20

He et al.

2003

China

CGH

yes

26

yes

14

yes

12

2/3/4

21

Leslie et al.

2003

UK

CGH

yes

50

no

(21)

no

(29)

1/2/3

22

Bardi et al.

2004

Sweden/Denmark

CGH

yes

115

no

(51)

no

(63)

1/2/3/4

23

Diep et al.

2004

Norway/Sweden

CGH

yes

10

no

(x)

no

(x)

(3)/4

24

Nakao et al.

2004

Spain

aCGH

yes

125

no

(x)

no

(x)

1/2/3/4

25

Poeaim et al.

2005

Thailand

CGH

yes

40

no

(10)

no

(30)

 

26

Tanami et al.

2005

Japan

CGH

yes

20

yes

9

yes

11

(2)/(3)/4

27

Al-Mulla et al.

2006

UK/Kuwait

CGH

yes

70

no

(47)

no

(18)

1/2

28

Grade et al.

2006

Germany

CGH

yes

21

yes

21

no

0

2/3

29

Grade et al. a

2007

Germany

CGH

yes

32

no

0

yes

32

2/3

30

Lips et al.

2007

the Netherlands

SNPa

yes

77

yes

77

no

0

1/2/3

31

Xiao et al.

2007

China

CGH

yes

24

yes

9

yes

15

 

32

Lips et al.

2008

the Netherlands

SNPa

yes

32

yes

32

no

0

1/2/(3)

33

Grade et al. a

2009

Germany

CGH

yes

42

yes

42

no

0

1/2/3

34

Lagerstedt et al.

2010

Sweden

aCGH

yes

24

no

(x)

no

(x)

1/2/3/4

35

Molinari et al.

2011

Italy

aCGH

yes

51

yes

51

no

0

1/2/3

36

Nakao et al.

2011

Japan

aCGH

yes

94

no

(x)

no

(x)

1/2/3/4

37

Chen et al. b

2011/2012

USA

aCGH

yes

95

yes

95

no

0

2/3

38

Kodeda et al.

2012

Sweden

aCGH

yes

16

yes

16

no

0

1/2/3

39

Shi et al.

2012

China

aCGH

yes

8

yes

8

no

0

 

40

Liang et al.

2013

China

aCGH

yes

48

yes

48

no

0

2/3/4

41

Zhou et al.

2013

China

aCGH

yes

16

yes

16

no

0

2/3

42

Doyen et al.

2014

France/Germany

SNPa

yes

80

yes

80

no

0

(1/2/3)

43

This study

2014

the Netherlands

SNPa

yes

112

yes

112

no

0

1/2/3

 

Total

 

43

 

20

 

12

  
  1. This table lists the published studies on CN alterations in rectal carcinomas used for comparisons with the present study (Nr. 43).
  2. Abbreviations: CGH, comparative genome hybridization; aCGH, arrayCGH; SNPa, SNP array; aUnclear if there is overlap with study Nr. 29 (Grade et al. [29]), bChen et al. published two papers based on the same patient cohort. Numbers in parentheses indicate the number of rectal or colon cancer patients included in the study, but for which results could not be distinguished between groups.